Submit Deal

FREELINE THERAPEUTICS

Summary

Freeline is a biotechnology company focused on developing curative gene therapies for chronic systemic diseases.

Deals Overview

Total Deals3

Valued Deals3

Total Value£ 124 M

Avg. Deal Size£ 41 M

Market Context

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy